About Third Arc Bio
Third Arc Bio is advancing antibody technology by unlocking the powerful biology of immune synapses to address solid tumors and autoimmune diseases.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Boston, United States
Team Size
11-50
Tracked Since
Sep 29, 2026
Web & Domain Identity
Official Website
thirdarcbio.com
Domain Registered Date
Feb 23, 2024
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $52,000,000 · Series-A
fundraisingfox.com
- Capital Raise
Raised $165,000,000 · Series-A
- Milestone
Website domain registered
thirdarcbio.com
Investors & Backers
AbbVie
Aberdeen
Alderline Group
Andreessen Horowitz
Biotechnology Value Fund
Cormorant Asset Management
Foresite Capital
Galapagos
Goldman Sachs Alternatives
Hillhouse Investment
Janus Henderson Investors
Logos Capital
Marshall Wace
Omega Funds
T. Rowe Price
Vida Ventures
Funding History
Series-A
· Feb 4, 2026
$52,000,000 fundraisingfox.com
Series-A
· Jul 22, 2024
$165,000,000 Source
Founders & Leadership
Sanjaya Singh
Founder and Chief Scientific Officer
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026